These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16619549)

  • 1. Thymidylate synthase and dihydropyrimidine dehydrogenase expressions in gallbladder cancer.
    Ajiki T; Hirata K; Okazaki T; Horiuchi H; Fujita T; Habara K; Kamigaki T; Suzuki Y; Kuroda Y
    Anticancer Res; 2006; 26(2B):1391-6. PubMed ID: 16619549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population study of expression of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with solid tumors.
    Fukushima M; Morita M; Ikeda K; Nagayama S
    Int J Mol Med; 2003 Dec; 12(6):839-44. PubMed ID: 14612954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
    Anticancer Res; 1999; 19(6C):5635-40. PubMed ID: 10697632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
    Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
    Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase and dihydropyrimidine dehydrogenase are upregulated in pancreatic and biliary tract cancers.
    Shimoda M; Sawada T; Kubota K
    Pathobiology; 2009; 76(4):193-8. PubMed ID: 19571608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis].
    Li HX; Zh S; Zhang YH; Risberg B; Karlsson MG; Nesland JM
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):669-72. PubMed ID: 15777505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
    Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
    Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
    Inoue K; Takao M; Watanabe F; Tarukawa T; Shimamoto A; Kaneda M; Sakai T; Fukushima M; Shimpo H; Yada I
    Lung Cancer; 2005 Jul; 49(1):47-54. PubMed ID: 15949589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL; Yokomise H; Kobayashi S; Fukushima M; Hitomi S; Wada H
    Int J Oncol; 2000 Jul; 17(1):47-54. PubMed ID: 10853017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
    Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H; Shirakawa K; Ohsawa T; Sobajima J; Hayashi Y; Nakada H; Yokoyama M; Hashimoto D
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1929-34. PubMed ID: 16282729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
    Fakhrejahani E; Miyamoto A; Tanigawa N
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
    Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
    Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
    Kawasaki G; Yoshitomi I; Yanamoto S; Mizuno A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):717-23. PubMed ID: 12464897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
    Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer.
    Nakayama Y; Inoue Y; Nagashima N; Katsuki T; Matsumoto K; Kadowaki K; Shibao K; Tsurudome Y; Hirata K; Sako T; Nagata N; Itoh H
    Anticancer Res; 2005; 25(6A):3755-61. PubMed ID: 16302736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of dihydropyrimidine dehydrogenase and thymidylate synthase expression in gastric carcinoma and colonic carcinoma].
    Yoshida T; Shimooki O; Baba Y; Abe T; Sugai T; Nakamura S
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):183-7. PubMed ID: 15751630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.